NCT04008875

Brief Summary

Justification: The diaphragm is the main inspiratory muscle. Its dysfunction therefore compromises ventilation, which is necessary for gas exchange. Diaphragmatic dysfunction is frequently observed in resuscitation patients. Diaphragm ultrasound is currently a simple and validated technique for measuring the function of the diaphragm in intensive care. However, the discontinuity of the measurements is one of the major limitations of the current, standard ultrasonic evaluation of diaphragm function. Respinor AS (Oslo, Norway) has developed an ultrasound device (known as RESPINOR DXT) for continuous quantification of diaphragmatic excursion and velocity. Aims of the study: To evaluate the feasibility of the continuous monitoring of the diaphragmatic excursion using RESPINOR DXT in patients undergoing MV in the intensive care unit, to ensure its reliability and to establish a link between the diaphragmatic excursion and the weaning outcome of MV. Method: In addition to continuous diaphragm monitoring by RESPINOR DXT, a daily measurement of the diaphragm excursion will be performed using a conventional ultrasound system for comparison. A daily measurement of the oesophageal pressure (Pes) and the gastric pressure (Pga) will be performed, thus allowing the calculation of the transdiaphragmatic pressure (Pdi). Analysis: The feasibility of the measurement will be evaluated through user utility questions as well as the time spent with a signal meeting specific quality criteria. Its reliability will be studied by the concordance between the measurements of the excursion measured by RESPINOR DXT and by standard ultrasound (Bland-Altman, Passing-Bablock). It will be further evaluated by the correlation between the variations of the excursion measured by RESPINOR DXT and the Pdi variations. Receiver operating characteristic (ROC) curves will be performed to identify the optimal diaphragmatic excursion threshold for predicting weaning success and prognosis. Hypothesis: It is anticipated that the present study will show that the continuous monitoring of diaphragm excursion by RESPINOR DXT is reliable. Further, it is anticipated that there will be a statistical link between the diaphragmatic excursion and velocity of the movement measured by RESPINOR DXT before, during and after the spontaneous breathing trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2019

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 11, 2019

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 12, 2019

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 5, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 8, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 14, 2020

Completed
Last Updated

June 14, 2021

Status Verified

June 1, 2021

Enrollment Period

1.2 years

First QC Date

April 12, 2019

Last Update Submit

June 11, 2021

Conditions

Keywords

diaphragm ultrasoundmechanical ventilationdiaphragm function

Outcome Measures

Primary Outcomes (2)

  • User-completed 5-point utility questions

    Five-point scale to assess ease of application of the device. Scale used has options of very difficult, difficult, neutral, easy, very easy, with very easy being the better outcome and very difficult the worst.

    Day 1 of enrolment

  • Incidence of pressure sores.

    The investigators will measure the incidence of pressure sores at the site of the investigative device sensors in patients throughout the period of enrolment.

    Up to 14 days (the period of enrolment of the patient)

Secondary Outcomes (3)

  • Concordance between diaphragm excursion measurements.

    Up to 14 days (the period of enrolment of the patient)

  • Changes in diaphragm excursion during the SBT.

    From 30 minutes before the SBT up to 30 minutes post-SBT

  • Correlation between the diaphragm velocity and transdiaphragmatic pressure measurements.

    From 30 minutes before the SBT up to 30 minutes post-SBT

Study Arms (2)

Successful weaning/extubation

Successful weaning will be defined as a patient who completes a planned 30-minute spontaneous breathing trial. Successful extubation will be defined as a patient who completes a planned 30-minute spontaneous breathing trial and is not reintubated in the first 48 hours after extubation.

Failed weaning/extubation

Failed weaning will be defined as a patient who did not complete a planned 30-minute spontaneous breathing trial. Failed extubation will be defined as a patient who did not complete a planned 30-minute spontaneous breathing trial, in the first 48 hours after extubation are reintubated, have unplanned non-invasive ventilation (NIV) or who have a tracheostomy.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients on mechanical ventilation in the intensive care unit for greater than 24 hours

You may qualify if:

  • Over 18 years old
  • Consent to participate in the study
  • Affiliation to a social security scheme or entitled to it
  • Invasive mechanical ventilation for ≥ 24 hours
  • Richmond Agitation Sedation Scale (RASS) ≥ - 3 (Moderate sedation)
  • Able to tolerate spontaneous ventilation with inspiratory support ≤ 28 cmH2O
  • Absence of high-dose vasopressors defined by noradrenaline dosage \< 0.3 μg / kg / min

You may not qualify if:

  • Central or spinal neurological lesion involving central ventilatory control or its transmission
  • Contraindication to the insertion of the oesophageal catheter, ie any contraindication to insertion or change of gastric tube, esophageal surgery of less than 14 days, oesophageal varices rupture of less than 4 days
  • Known neuromuscular disease, curare less than 24 hours (excluding succinylcholine for rapid sequence intubation), known hemidiaphragm paralysis or suspicion of hemidiaphragm paralysis (defined by elevation) dome\> 2.5 cm compared to contralateral dome
  • Patient in therapeutic limitation
  • Pregnant woman, minor patient or protected adult

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

CHU Angers

Angers, France

Location

CH Saint Joseph Saint Luc

Lyon, France

Location

Hôpital Universitaire Pitié Salpêtrière

Paris, France

Location

Related Publications (9)

  • Jiang JR, Tsai TH, Jerng JS, Yu CJ, Wu HD, Yang PC. Ultrasonographic evaluation of liver/spleen movements and extubation outcome. Chest. 2004 Jul;126(1):179-85. doi: 10.1378/chest.126.1.179.

    PMID: 15249460BACKGROUND
  • Spadaro S, Grasso S, Mauri T, Dalla Corte F, Alvisi V, Ragazzi R, Cricca V, Biondi G, Di Mussi R, Marangoni E, Volta CA. Can diaphragmatic ultrasonography performed during the T-tube trial predict weaning failure? The role of diaphragmatic rapid shallow breathing index. Crit Care. 2016 Sep 28;20(1):305. doi: 10.1186/s13054-016-1479-y.

    PMID: 27677861BACKGROUND
  • Jaber S, Petrof BJ, Jung B, Chanques G, Berthet JP, Rabuel C, Bouyabrine H, Courouble P, Koechlin-Ramonatxo C, Sebbane M, Similowski T, Scheuermann V, Mebazaa A, Capdevila X, Mornet D, Mercier J, Lacampagne A, Philips A, Matecki S. Rapidly progressive diaphragmatic weakness and injury during mechanical ventilation in humans. Am J Respir Crit Care Med. 2011 Feb 1;183(3):364-71. doi: 10.1164/rccm.201004-0670OC. Epub 2010 Sep 2.

    PMID: 20813887BACKGROUND
  • Levine S, Nguyen T, Taylor N, Friscia ME, Budak MT, Rothenberg P, Zhu J, Sachdeva R, Sonnad S, Kaiser LR, Rubinstein NA, Powers SK, Shrager JB. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med. 2008 Mar 27;358(13):1327-35. doi: 10.1056/NEJMoa070447.

    PMID: 18367735BACKGROUND
  • Kim WY, Suh HJ, Hong SB, Koh Y, Lim CM. Diaphragm dysfunction assessed by ultrasonography: influence on weaning from mechanical ventilation. Crit Care Med. 2011 Dec;39(12):2627-30. doi: 10.1097/CCM.0b013e3182266408.

    PMID: 21705883BACKGROUND
  • Llamas-Alvarez AM, Tenza-Lozano EM, Latour-Perez J. Diaphragm and Lung Ultrasound to Predict Weaning Outcome: Systematic Review and Meta-Analysis. Chest. 2017 Dec;152(6):1140-1150. doi: 10.1016/j.chest.2017.08.028. Epub 2017 Aug 31.

    PMID: 28864053BACKGROUND
  • Zambon M, Greco M, Bocchino S, Cabrini L, Beccaria PF, Zangrillo A. Assessment of diaphragmatic dysfunction in the critically ill patient with ultrasound: a systematic review. Intensive Care Med. 2017 Jan;43(1):29-38. doi: 10.1007/s00134-016-4524-z. Epub 2016 Sep 12.

    PMID: 27620292BACKGROUND
  • Farghaly S, Hasan AA. Diaphragm ultrasound as a new method to predict extubation outcome in mechanically ventilated patients. Aust Crit Care. 2017 Jan;30(1):37-43. doi: 10.1016/j.aucc.2016.03.004. Epub 2016 Apr 22.

    PMID: 27112953BACKGROUND
  • Demoule A, Fosse Q, Mercat A, Bergum D, Virolle S, Bureau C, Mellemseter M, Guichou R, Similowski T, Dres M, Mortaza S. Operator independent continuous ultrasound monitoring of diaphragm excursion predicts successful weaning from mechanical ventilation: a prospective observational study. Crit Care. 2024 Jul 16;28(1):245. doi: 10.1186/s13054-024-05003-0.

MeSH Terms

Conditions

Respiratory Aspiration

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Alexandre Demoule, MD

    Hôpital Universitaire Pitié Salpêtrière

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 12, 2019

First Posted

July 5, 2019

Study Start

April 11, 2019

Primary Completion

July 8, 2020

Study Completion

October 14, 2020

Last Updated

June 14, 2021

Record last verified: 2021-06

Locations